Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland

Multiple Sclerosis

Volumn 14, Issue 7, 2008, Pages 880-886

  Gray, O M ^a   McDonnell, G V ^a   Hawkins, S A ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Epidemiology; Incidence; Multiple sclerosis; Prevalence

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FACTORIAL ANALYSIS; FEMALE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; INCIDENCE; IRELAND; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT ASSESSMENT; POPULATION RESEARCH; PRACTICE GUIDELINE; PREVALENCE; SEX DIFFERENCE; STANDARDIZATION; ADOLESCENT; AGE DISTRIBUTION; CHILD; EPIDEMIOLOGY; MIDDLE AGED; RISK FACTOR; SEX RATIO; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BIAS (EPIDEMIOLOGY); CHILD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NORTHERN IRELAND; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION;

EID: 54449101850     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458508090663     Document Type: Article

References (40)

1. Allison RS, Millar JHD,. Prevalence of disseminated sclerosis in Northern Ireland. Ulster Med J 1954; 23: 5-27.
2. Millar JHD,. Multiple sclerosis in Northern Ireland. In: FC Rose, (ed), Clinical Neuroepidemiology. Tunbridge Wells: Pitman Medical; 1980: 222-227.
3. Hawkins S, McKee F,. Updated epidemiological studies of multiple sclerosis in Northern Ireland. J Neurol 1988; 235: S86.
4. McDonnell GV, Hawkins SA,. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 1998; 50: 423-428.
5. Poser CM, Paty DW, Scheinberg L,. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983; 13: 227-231.
6. McDonald WI, Compston A, Edan G. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
7. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
8. Bing RRH,. Die multiple sclerose in der nord west schwiez. Schweiz Med Wochenschr 1926; 56: 30-34.
9. Allison RS,. Disseminated sclerosis in North Wales: An inquiry into its incidence, frequency, distribution and other etiological factors. Brain 1931; 53: 391-430.
10. Murray S, Bashir K, Penrice G, Womersley SJ,. Epidemiology of multiple sclerosis in Glasgow. Scott Med J 2004; 49: 100-104.
11. Fox CM, Bensa S, Bray I, Zajicek JP,. The epidemiology of multiple sclerosis in Devon: A comparison of the new and old classification criteria. J Neurol Neurosurg Psychiatry 2004; 75: 56-60.
12. Forbes RB, Wilson SV, Swingler RJ,. The prevalence of multiple sclerosis in Tayside, Scotland: Do latitudinal gradients really exist. J Neurol 1999; 246: 1033-1040.
13. Robertson N, Compston A,. Surveying multiple sclerosis in the United Kingdom. J Neurol Neurosurg Psychiatry 1995; 58: 2-6.
14. Grant RM, Carver AD, Sloan RL,. Multiple sclerosis in Fife. Scott Med J 1998; 43: 44-47.
15. Rothwell PM, Charlton D,. High incidence and prevalence of multiple sclerosis in south east Scotland: Evidence of a genetic predisposition. J Neurol Neurosurg Psychiatry 1998; 64: 730-735.
16. Robertson N, Deans J, Fraser M, Compston DA,. Multiple sclerosis in south Cambridgeshire: Incidence and prevalence based on a district register. J Epidemiol Community Health 1996; 50: 274-279.
17. Robertson N, Deans J, Fraser M, Compston DA,. Multiple sclerosis in the north Cambridgeshire districts of East Anglia. J Neurol Neurosurg Psychiatry 1995; 59: 71-76.
18. Rice-Oxley M, Williams ES, Rees JE,. A prevalence survey of multiple sclerosis in Sussex. J Neurol Neurosurg Psychiatry 1995; 58: 27-30.
19. Mumford CJ, Fraser MB, Wood NW, Compston DA,. Multiple sclerosis in the Cambridge health district of East Anglia. J Neurol Neurosurg Psychiatry 1992; 55: 877-882.
20. Shepherd DI, Downie AW,. A further prevalence study of multiple sclerosis in north-east Scotland. J Neurol Neurosurg Psychiatry 1980; 43: 310-315.
21. Shepherd DI, Downie AW. Prevalence of multiple sclerosis in north-east Scotland. Br Med J 1978; 2: 314-316.
22. Poskanzer DC, Prenney LB, Sheridan JL, Kondy JY,. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology. J Epidemiol Community Health 1980; 34: 229-239.
23. Sutherland JM,. Observations on the prevalence of multiple sclerosis in Northern Scotland. Brain 1956; 79: 635-654.
24. Fog M, Hyllested K,. Prevalence of disseminated sclerosis in the Faroes, the Orkneys and Shetland. Acta Neurol Scand 1966; 42: 9-11.
25. Cook SD, Cromarty JI, Tapp W, Poskanzer D, Walker JD, Dowling PC,. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985; 35: 545-551.
26. Poskanzer DC, Schapira K, Miller H,. Epidemiology of multiple sclerosis in the counties of Northumberland and Durham. J Neurol Neurosurg Psychiatry 1963; 26: 368-376.
27. Hargreaves ER,. Epidemiological studies in Cornwall. Proc R Soc Med 1961; 54: 209-216.
28. Roberts MH, Martin JP, McLellan DL, McIntosh-Michaelis SA, Spackman AJ,. The prevalence of multiple sclerosis in the Southampton and South West Hampshire Health Authority. J Neurol Neurosurg Psychiatry 1991; 54: 55-59.
29. Swingler RJ, Compston DA,. The prevalence of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1988; 51: 1520-1524.
30. Phadke JG, Downie AW,. Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland-an update. J Epidemiol Community Health 1987; 4: 5-13.
31. Williams ES, McKeran RO,. Prevalence of multiple sclerosis in a south London borough. Br Med J 1986; 293: 237-239.
32. Poskanzer DC, Walker AM, Yonkondy J, Sheridan JL,. Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 1976; 26: 14-17.
33. Hennessey A, Swingler RJ, Compston DAS,. The incidence and mortality of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatry 1989; 52: 1085-1089.
34. Forbes RB, Swingler RJ,. An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology 1999; 52: 215-216.
35. Houzen H, Niino M, Kikuchi S,. The prevalence and clinical characteristics of MS in northern Japan. J Neurol Sci 2003; 211: 49-53.
36. Barnett MH, Williams DB, Day S, Macaskill P, McLeod JG,. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: A 35-year study. J Neurol Sci 2003; 213: 1-6.
37. Wallin MT, Page WF, Kurtzke JF,. Multiple sclerosis in US veterans of the Vietnam era and later military service: Race, sex and geography. Ann Neurol 2004; 55: 65-71.
38. Noonan CW, Kathman SJ, White MC,. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002; 58: 136-138.
39. Midgard R, Riise T, Svanes C, Kvale G, Nyland H,. Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991: An age-period-cohort analysis. Brain 1996; 119: 203-211.
40. Orton SM, Herrera BL, Yee IM,. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006; 5: 932-933.